Using CBD Oil to Treat Severe Epilepsy in Children, with Dr. Richard Huntsman
Release Date: 07/10/2022
Researchers Under the Scope
Most childhoods don’t involve sitting at the hospital for an infusion of medication, transfusions on weekends, or worrying that classmates will comment on the colour of your skin. For one Saskatoon teen with an ultra-rare blood disease, that’s everyday life. She was diagnosed with a form of anemia so uncommon only a handful of cases have been identified globally. In this episode, & share how they’re working to change her “normal” by opening a phase 3 pharmaceutical trial and fighting for a better quality of life. We hear how Tehseen and Felton each got into...
info_outlineResearchers Under the Scope
Peter Hedlin (PhD, MD) recalls being a ‘young, naïve medical student’ when he asked a mentor a question that’s stuck with him for years. “I remember asking how anaesthetics work on the brain,” said Hedlin. “And he said, ‘we actually don’t really know’. And I thought that was crazy.” Today, at the University of Saskatchewan’s College of Medicine. He examines what surgery and sedation do to the human body — in particular, to aging brains. Trained first as a microbiologist who earned his PhD as a vaccine researcher at , Hedlin was always drawn to medicine. He...
info_outlineResearchers Under the Scope
In this episode, medical student and researcher shares what large provincial datasets reveal about opioid use disorder, maternal mental health, and pregnancy. Armed with data, she hopes better support —before, during, and after birth—can change outcomes for mothers and babies. Lanke spent her summer working with epidemiologist and the Saskatchewan Population Health and Evaluation Research Unit on a pan-Canadian project tracking opioid use in perinatal populations across five provinces. “The question we set out to answer was: What is the association between...
info_outlineResearchers Under the Scope
As a student, Jack Walther's friends often came to him when they needed a listening ear, or help with relationship struggles. This summer, Walther took his fascination with the brain and mood disorders to , learning to untangle some of the tiny molecular threads that might explain why depression so often shows up alongside dementia. Walther and the research team dug into the physical interactions between serotonin and the beta amyloid peptides that build up in patients with Alzheimer's disease. . He admits going from the classroom to the laboratory felt like a sharp learning curve. "It was...
info_outlineResearchers Under the Scope
Eve Simpson knows from experience scientific research doesn’t always follow a linear path. In the first of three student research episodes, the fourth-year biochemistry, microbiology and immunology student looks back at a summer spent decoding Eastern Equine Encephalitis Virus (EEEV) in ’s lab. Simpson said she loved doing bench research, but felt frustrated in the moments where she hit setbacks and moments of doubt. “I felt like I was letting everyone down,” she said. “But everyone I spoke to said they'd been through that. It's part of being a researcher. That's what drives us to do...
info_outlineResearchers Under the Scope
Jessica Sheldon (PhD) is on a mission to starve out Acinetobacter baumannii —one of the world’s most virulent hospital-borne pathogens. Notorious for its speedy evolution and multi-drug resistance, the hospital-borne bacteria lingers on dry surfaces and infects critically-ill patients, leading to sepsis, pneumonia and high mortality rates. In this episode, delves into the real-life events that drove her to investigate histamine, and its role in bacterial survival and immune response. In 2022, Sheldon joined the University of Saskatchewan’s College of Medicine as an assistant professor...
info_outlineResearchers Under the Scope
Kirk Haan graduated from high school, thinking he’d study pharmacy at the University of Saskatchewan, and walk out five years later. After one summer at a pharmacy, Haan realized he was after a more ‘hands-on’ career in medicine. “I’ve kind of worked with my hands my whole life, just between rummaging around on a farm and always kind of building things,” he said. “Now it’s using them to help people in a direct way.” Then, Haan found his passion — inside the laboratory. In 2018, Haan landed a summer position in , studying osmoregulation — the mechanisms that govern...
info_outlineResearchers Under the Scope
Sébastien Gauvrit (PhD) was only ten when his family let him have his first tank of guppies. Within weeks, he was hooked. “I actually had to understand genetics directly by mixing these different fish together to get the colour or fin shape I was interested in,” said the vascular biologist and genetic modelling pioneer. From his home in France, to post-doctoral work pioneering new models for vascular disease in Germany, to his current position as an assistant professor of Anatomy, Physiology and Pharmacology at the University of Saskatchewan’s College of Medicine — tropical fish...
info_outlineResearchers Under the Scope
Stuart Skinner (MD) knew something was wrong three years ago, when patients started coming to him with vision loss, fever, rashes, and meningitis. Almost every case could be traced back to untreated syphilis — a sexually transmitted infection with caseloads exploding 1,200 per cent from 2017. Saskatchewan saw this spike just as Covid-19 entered the picture. “With the pandemic, testing dropped dramatically,” Skinner said, noting this , often travelling alongside HIV. Syphilis often spreads through sores, and can remain unnoticed for months or years on end, making early detection...
info_outlineResearchers Under the Scope
Yi-Chun Chen (PhD) is taking a close-up look at some of the body’s hardest-working cells — the ones often processing an overabundance of modern-day food and nutrients. “From an evolutionary point of view, our cells are not designed to deal with that,” said Chen, who joined the department of Anatomy, Physiology, and Pharmacology at the University of Saskatchewan last year as an assistant professor. She said our bodies are pushed into churning out large amounts of insulin rapidly after snacks and meals, “which makes the beta cells work extra hard.” Raised in Taiwan and inspired by...
info_outlineAs a pediatric neurologist, Dr. Richard Huntsman sees the children with the most medically complex epilepsy
"It completely disrupts the life of a family," said Huntsman. "Limitations on what the child can do, limitations on what the family can do."
"When the kids have really severe and difficult-to-control epilepsy, It's a huge burden on their parents."
Eight years ago, parents started asking Huntsman about whether they could try treating their childrens' seizures -- with cannabis.
Back then, Canadian health officials allowed doctors to prescribe the medical use of dried marijuana buds -- which meant smoking them.
"No pediatrician would recommend that for a child," said Huntsman, who said any therapeutic benefits and dosages for cannabis products at the time amounted to a big question mark.
"I was maybe a little bit skeptical that we would see huge improvements," Huntsman said.
As an associate professor of pediatric neurology in the College of Medicine, Huntsman knew CBD and THC contain anticonvulsants.
He wanted high-quality, independent data, so he designed an investigator-sponsored study to test cannabis on epileptic children.
"I certainly did raise eyebrows when I went to the different funding agencies," he said, crediting his department, the Saskatchewan Health Research Foundation, and the Jim Pattison Children's Hospital Foundation for their financial backing.
"That took a lot of courage."
Huntsman and his team approached Saskatoon-area licenced producer CanniMed, Canada's first licenced producer of medical marijuana, to create a food-grade CBD oil for children with a targeted ingredient list.
"We knew exactly what was in it with regards to concentrations of cannabidiol, THC, and to a lesser degree other cannabinoids which are present in these compounds," Huntsman said.
He then recruited 20 Canadian children with drug-resistant, medically severe epilepsy started by recording their baseline seizure frequency. Eleven of them attended monthly appointments in Saskatoon, to participate in the study.
Parents turned in detailed medical journals each visit, including changes they observed in their child and in their family's quality of life.
The CBD oil worked.
"The reduction in seizure frequency was around 60 per cent." said Huntsman, calling the findings 'really significant'.
Although not all children responded the same way, Huntsman was even more surprised to see a number of children become entirely seizure-free by the end of the study.
"These were kids who'd tried multiple multiple medications, had tried ketogenic diets, had tried things like steroids, etc to control their seizures."
In this episode, we hear how those patients are doing today, and why one young boy's case became a true 'aha' moment for Huntsman.
"He was interacting more, he was laughing at funny bits of movies, which he'd never done before." said Huntsman.
Huntsman founded the Cannabinoid Research Initiative of Saskatchewan, hoping to join forces with other biomedical researchers to learn more about CBD and THC, and whether they're more effective in combinations or alone.
In this episode, we also hear where Huntsman wants to see more research, with hundreds of cannabinoids and potential compounds to explore.